| Definitions | |
| APC | Antigen-presenting cells |
| CAF | Cancer-associated fibroblasts (CAFs) |
| CD | Cluster of Differentiation |
| CEACAM | Carcinoembryonic antigen-related cell adhesion molecules |
| CRC | Colorectal cancer |
| CTLA-4 | Cytotoxic T-lymphocyte associated protein-4 |
| CTX | Chemotherapy |
| dMMR | Deficient mismatch repair |
| DCA | Deoxycholic acid |
| DC | Dendritic cells |
| EBV | Epstein Barr virus |
| ECM | Extracellular matrix |
| FMT | Fecal microbiota transplantation |
| 5-FU | 5-fluorouracil |
| GC | Gastric cancer |
| HBV | Hepatitis B virus |
| HCV | Hepatitis C virus |
| HIF | Hypoxia-inducible factor |
| HPV | Human papillomavirus |
| HTLV-1 | Human T-cell lymphotropic virus type 1 |
| ICIs | Immune checkpoint inhibitors |
| irAEs | Immune-related adverse events |
| ITIM | Immunoreceptor tyrosine-based inhibitory motifs |
| LAG-3 | Lymphocyte activation gene 3 |
| LPS | Lipopolysaccharide |
| MDSCs | Myeloid-derived suppressor cells |
| MSI-H | Microsatellite instability-high |
| NK | Natural killer |
| PDAC | Pancreatic ductal adenocarcinoma |
| PD-1 | Programmed cell death protein-1 |
| PD-L1 | Programmed cell death protein-1 ligand |
| PRR | Pattern recognition receptors |
| ROS | Reactive oxygen species |
| RT | Radiation therapy |
| SCFA | Short-chain fatty acids |
| TAMs | Tumor-associated macrophages |
| TIM-3 | T-cell immunoglobulin and mucin domain 3 |
| TIME | Tumor-immune microenvironment |
| TIGIT | T-cell immunoglobulin and ITIM |
| TIL | Tumor-infiltrating lymphocytes |
| TME | Tumor microenvironment |
| Tregs | Regulatory T cells |